A gut microbiome-derived risk score is associated with future cancer development
This study demonstrates that a gut microbiome-derived risk score, based on 28 microbial species, can predict the future development of cancer up to a decade before diagnosis, highlighting the microbiome's potential as a novel biomarker for early cancer risk stratification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
For decades, scientists have understood that the trillions of tiny organisms living inside our intestines do more than just help us digest food. This community, known as the gut microbiome, acts as a central hub for our immune system and metabolism, constantly interacting with the cells that line our gut. When this community falls out of balance—a state researchers call dysbiosis—it has long been linked to the development of cancer, particularly in the digestive tract. However, a critical question has remained unanswered: does this imbalance happen because of the cancer, or does it appear years before the disease is even detected? Most previous studies have looked at people who already had cancer, making it impossible to tell if the microbial changes were a cause or a consequence. To solve this puzzle, researchers needed to look forward in time, examining the gut bacteria of healthy people and waiting to see who would develop cancer years later.
A team of scientists set out to answer this by studying nearly 6,000 adults from a large Dutch health study called Lifelines. These participants had provided stool samples between 2013 and 2016, which were analyzed using a technique that reads the genetic material of every microbe present, creating a detailed snapshot of their gut communities. The researchers then linked these samples to national health records, tracking the participants for up to ten years to see who received a cancer diagnosis. During this follow-up period, 245 people were diagnosed with cancer, while the vast majority remained cancer-free. By comparing the gut bacteria of those who eventually got sick with those who stayed healthy, the team discovered that specific patterns in the microbiome could indeed signal future risk. They developed a scoring system based on the presence or absence of 28 different types of bacteria. People with higher scores on this scale were significantly more likely to be diagnosed with cancer in the coming years, even after the researchers accounted for known risk factors like age, body weight, and smoking habits.
The strength of this finding lies in its timing. The bacterial signatures were detectable in stool samples taken years before any clinical symptoms appeared or any cancer was found. The researchers calculated that for every standard increase in this risk score, a person's likelihood of developing cancer rose by a substantial margin. This pattern held true across various types of cancer, including breast, prostate, and gastrointestinal cancers, suggesting that the gut microbiome might harbor a general warning signal for the disease rather than just a sign of one specific tumor type. To ensure this was not a fluke of the Dutch population, the team tested their scoring system on completely different groups of people, including thousands of patients from other studies and a separate Finnish population. In these external groups, the score successfully distinguished between people who had cancer and those who did not, and in the Finnish group, it again showed a trend where higher scores correlated with a lower chance of remaining cancer-free over time.
Importantly, the study ruled out several alternative explanations for these results. The researchers found that the risk score was not simply a marker for other common diseases like heart problems or obesity, nor was it linked to non-cancerous conditions present at the start of the study. This suggests the bacterial pattern is specifically tied to cancer risk rather than general poor health. The team also noted that the score did not rely on a single "bad" bacterium but was instead a complex mix of many different species, some of which were more common in people who developed cancer and others that were less common. While some of these bacteria had been hinted at in previous research on established cancer, many were new candidates that had never been linked to the disease before.
Despite these promising results, the authors are careful to state that this is not yet a tool for diagnosing cancer in a doctor's office. The study shows a strong association, but it does not prove that changing the gut bacteria will prevent cancer, nor does it confirm that these microbes are the direct cause of the disease. It is possible that the bacteria are reacting to early, undetected changes in the body that precede a tumor. The researchers also point out that they only took one sample from each person, so they cannot be sure if these bacterial patterns stay stable over a lifetime or if they fluctuate. Nevertheless, this work provides the first solid evidence that the gut microbiome contains a detectable signature of future cancer risk years before a diagnosis is made. It opens a new door for understanding how our internal ecosystems interact with our long-term health and suggests that in the future, a simple stool test might one day help identify individuals who need closer monitoring for cancer long before it becomes a clinical reality.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.